Mietlicki-BaaseEMcGrathLKoch-LaskowskiKKrawczykJReinerDPhamTet alAmylin receptor activation in the ventral tegmental area reduces motivated ingestive behavior
Emergency and travel scenarios Travel situations may necessitate temporary room temperature storage
Do not start, stop, or change any medication without speaking to your healthcare provider
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
When they injected GLP-1 into the brains of hungry rats, the animals lost interest in their food
BPC-157 has shown promise in promoting healing in various types of injuries, including tendon, muscle, and bone damage
